Hims & Hers Health (HIMS) is jumping 15% after the company announced that it had made an acquisition which will allow it to launch at-home lab testing. Hims & Hers owns and operates an online health and wellness platform.
The article from MSN discusses the significant stock rally of Hims & Hers Health, Inc. (NYSE: HIMS) following the announcement of their first-quarter earnings. The company reported a 46% year-over-year revenue increase to $278.2 million, surpassing Wall Street's expectations. This growth was driven by a 41% increase in subscribers to 1.7 million and a 57% rise in orders to 2.4 million. Additionally, Hims & Hers raised its full-year revenue guidance to between $1.20 billion and $1.23 billion, which was above the consensus estimate of $1.18 billion. The positive earnings report and optimistic future outlook led to a 25% surge in the company's stock price in pre-market trading. The company's focus on telehealth services for conditions like mental health, sexual health, and dermatology has evidently resonated well with consumers, contributing to the stock's rally.